The Orkla India IPO grey market (GMP) has shown strong activity ahead of the public issue. Formerly known as MTR Foods, Orkla India is a well-known name in the packaged foods segment. This update summarizes the latest GMP movement, key IPO facts, important dates, business highlights, reasons behind the GMP movement, expected listing gain, and an FAQ section to help investors make informed decisions.
Orkla India IPO GMP — Latest Movement
- GMP as of October 27, 2025: ₹160 (GMP Up) — implies an estimated listing gain of ~12.91% based on the upper price band of ₹730.
- October 25, 2025: GMP ₹145 — upward trend.
- October 24, 2025: GMP ₹115 — early signs of demand.
- October 23, 2025: No recorded grey market activity.
The grey market’s upward movement indicates positive short-term sentiment, but GMPs are unofficial and can change quickly.
Key IPO Highlights
- IPO Open Date: October 29, 2025
- IPO Close Date: October 31, 2025
- Price Band: ₹695 to ₹730 per share
- Face Value: ₹1 per equity share
- Issue Size: Approx ₹1,667.54 crores
- Offer for Sale (OFS): Approx 2,28,43,004 equity shares
- Issue Type: Book build issue
- Listing Venues: NSE & BSE
Important Timeline
- IPO Opens: October 29, 2025
- IPO Closes: October 31, 2025 (Bidding cut-off: 5 PM)
- Basis of Allotment: November 3, 2025
- Refunds Initiation / Credit to Demat: November 4, 2025
- Expected Listing Date: November 6, 2025
Business Overview
Orkla India (formerly MTR Foods) is a leading multi-category Indian food company with a legacy in packaged foods and convenience foods.
- Brands: MTR and Eastern (well-known in spice mixes, ready mixes, and convenience foods).
- Product Range: Over 400 SKUs across spices, blended masalas, convenience mixes (Rava Idli Mix, Dosa Mix, 3-Minute Poha), and ready-to-cook/ready-to-eat items.
- Distribution Footprint: Presence across 28 states and 5 union territories supported by 843 distributors and ~1,800 sub-distributors.
- Market Positioning: Strong household penetration in traditional and modern trade channels, with growing presence in convenience and ready-to-eat segments.
Why the GMP is Moving Up
- Strong brand recognition and household recall for MTR and Eastern.
- Positive sentiment around consumption plays and packaged foods.
- Healthy recent financial performance and perceived growth potential in convenience foods.
- Anticipated strong retail and institutional demand during bidding.
- Grey market activity reflecting short-term demand sentiment (not a guarantee of listing performance).
Expected Listing Gain
With GMP at ₹160 (as of Oct 27), the estimated listing gain is roughly 12–15% based on the upper band (₹730).
Note: GMP-based estimates are speculative. Final listing performance depends on actual subscription levels, market conditions, and macro sentiment at listing.
How Investors Should Use GMP Information
- Treat GMP as an early sentiment indicator only — it is unofficial and volatile.
- Evaluate company fundamentals, long-term growth prospects, and valuation before subscribing.
- Do not base an investment decision solely on GMP; use it alongside subscription data and financial metrics.
- If considering short-term listing gains, be aware of listing-day volatility and the risk of rapid price swings.
FAQs
What is Orkla India IPO GMP today?
₹160 as of October 27, 2025 (subject to change).
When does the Orkla India IPO open and close?
Opens October 29, 2025 — Closes October 31, 2025 (5 PM).
What is the Orkla IPO price band?
₹695 to ₹730 per share.
What is the expected listing date?
Expected listing on November 6, 2025 (subject to exchange confirmations).
Should I subscribe based on GMP?
No. GMP is unofficial. Subscribe only after evaluating fundamentals and risk tolerance.
The Orkla India IPO GMP and related grey market indicators quoted here are valid only on the date mentioned and are unofficial. Grey Market Premiums, Kostak rates, and Subject-to-Sauda prices are not regulated, may change rapidly, and do not guarantee listing performance. This information is for educational and informational purposes only and should not be construed as investment advice. Always review the company’s prospectus and fundamentals before making investment decisions.
Post a Comment